Skip to main content
. Author manuscript; available in PMC: 2015 Mar 1.
Published in final edited form as: Hypertension. 2013 Dec 16;63(3):572–579. doi: 10.1161/HYPERTENSIONAHA.113.01743

Figure 5. AngII-dependent diminished endothelial barrier antigen (EBA) expression in SHRs.

Figure 5

A–F, EBA staining within the PVN, NTS and RVLM of WKYs (A–C; n=5) and SHRs (D–E; n=5). G and H, EBA immunostainning (red) and isolectin IB4 (H) within the PVN of a WKYs. I, merged figure showing co-localization (yellow). J, mean EBA immunoreactivity density in WKY, SHR and SHR-LOS (n=3).***P<0.0001 vs. WKY and +++P<0.0001 vs. SHR. Scale bar: 50µm. 3V: third ventricle.